Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Times cited: 50
Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 313
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.
British journal of cancer.
Times cited: 44